FDA
-
-
-
-
-
-
-
Artiva Biotherapeutics Provides Update on Planned AlloNKĀ® Data Disclosures and Development Milestones for the Remainder of 2026
-
-
-
-
-
-
-
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors
-
-
-
-
-
-
-
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
-
334,268 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


